CRAIK, Charles

Professor, University of California San Francisco, Pharmaceutical Chemistry

Lab homepage

Charles Craik

Statement of interest

The ASBMB has supported me throughout my professional career. Access to major meetings and to more intimate, specialized symposia, introductions to a research community with mutual interests and opportunities to publish and review publications in journals related to my research area are some of the examples. I hope to return the favor by helping both young and more mature members of the association realize what the ASBMB can do for them.

In particular, I have benefited greatly from a productive relationship between discovery research in academia and practical applications in industry to help translate my work from the bench to the patient. The companies I have interacted with range from small start-up biotechnology companies to established pharmaceutical companies. Providing ASBMB leadership with a perspective of how healthy, transparent, productive partnerships can be established with industry is a primary goal of mine during my tenure on the Council of ASBMB.

In addition, having published in ASBMB journals for over three decades, I feel strongly about maintaining the quality and ready access of the journals to the scientific community and will help with the transition to open access.

Education and training

  • B.A., Chemistry, Allegheny College
  • M.A., Chemistry, Columbia University
  • Ph.D., Chemistry, Columbia University
  • Postdoctoral fellowship, Biochemistry and Biophysics, University of California, San Francisco

Awards and honors

  • Top 100 Innovators, Science Digest, 1985–1986
  • Lord Lecturer, Allegheny College, 2010
  • Fellow, American Association for the Advancement of Science, 2011
  • Member, Academy of Sciences of the Czech Republic Medal in Organic Chemistry & Biochemistry, 2013
  • National Academy of Inventors, 2015
  • Broom Lecturer, University of Utah, 2015
  • Lloyd Lecturer, Oregon Health and Science University, 2015
  • Protein Society Emil T. Kaiser Award, 2016
  • Member, American Academy of Arts and Sciences, 2017


  • Member, ASBMB, 1983–present
  • Editorial Board Member of BioTechniques, 1987–1997
  • Editorial Board Member of DNA, 1988
  • Associate Editor of Protein Engineering, 1988–2003
  • Nominating Committee for the Protein Society, Member, The Protein Society, 1989–1990
  • National Science Foundation Molecular Biochemistry Advisory Panel, 1993–1996
  • Vice Chair of Gordon Conference on Proteolytic Enzymes and Inhibitors, 1996
  • Chairman of Gordon Conference on Proteolytic Enzymes and Inhibitors, 1998
  • Co-organizer of the Cold Spring Harbor Meeting on the Biology of Proteolysis, 1997, 1999, 2001
  • Founder and Director of the Chemistry and Chemical Biology Graduate Program, 1998–2019
  • NIH, NIAID or NCI, Study Section Member, 2009–2019
  • HHMI Gilliam Fellowship Award Panel, 2015
  • Co-Director, Experimental Therapeutics, The Helen Diller Family Comprehensive Cancer Center, 2015–present
  • Guest Editor, eLife (Board of Reviewing Editors), 2017